CYTO Message Board - Msg: 8709601

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dan Sorenson who wrote (7471)	4/5/1999 12:51:00 PM
From: Dan Sorenson	Read Replies (1) of 8116

Quadramet for RA -------------------------->> Does anybody know whether Berlex has gotten around yet to deciding if they want to keep Quad for RA or is Cyto frothing at the mouth to buy it back for that potential indication? Was anything discussed on the conference call regarding this item? As you all may know, I am not a big believer in the Quad for RA theory. Not as an indication that would be financially successful in the marketplace by covering all it's development costs and then making money to increase shareholder value. I know that is a foreign concept for this companies mgmt. Dan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next